| 19088198 |
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Marzec, M,
Zhang, Q,
Goradia, A,
Raghunath, PN,
Liu, X,
Paessler, M,
Wang, HY,
Wysocka, M,
Cheng, M,
Ruggeri, BA,
Wasik, MA
|
Proc. Natl. Acad. Sci. U.S.A. |
2008 |
| 32483429 |
ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
Tong, L,
Li, J,
Li, Q,
Wang, X,
Medikonda, R,
Zhao, T,
Li, T,
Ma, H,
Yi, L,
Liu, P,
Xie, Y,
Choi, J,
Yu, S,
Lin, Y,
Dong, J,
Huang, Q,
Jin, X,
Lim, M,
Yang, X
|
Theranostics |
2020 |
| 30054295 |
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
Song, TL,
Nairismägi, ML,
Laurensia, Y,
Lim, JQ,
Tan, J,
Li, ZM,
Pang, WL,
Kizhakeyil, A,
Wijaya, GC,
Huang, DC,
Nagarajan, S,
Chia, BK,
Cheah, D,
Liu, YH,
Zhang, F,
Rao, HL,
Tang, T,
Wong, EK,
Bei, JX,
Iqbal, J,
Grigoropoulos, NF,
Ng, SB,
Chng, WJ,
Teh, BT,
Tan, SY,
Verma, NK,
Fan, H,
Lim, ST,
Ong, CK
|
Blood |
2018 |